Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

0.2516
-0.0394-13.54%
Post-market: 0.25900.0074+2.94%19:14 EDT
Volume:2.03M
Turnover:524.56K
Market Cap:11.59M
PE:-0.18
High:0.2800
Open:0.2800
Low:0.2400
Close:0.2910
Loading ...
May 04, 2023

Major Issues Report

Form 8-K - Current report
Mar 16, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2023

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 30, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 23, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 03, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 25, 2022

Major Issues Report

8-K - Current report
Sep 22, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Major Issues Report

8-K - Current report
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans